Patents Assigned to Taiho Pahrmaceutical Co., Ltd.
  • 5H-pyrrolo[2,3-D]pyrimidin-6(7H)-one derivative
    Patent number: 10538528
    Abstract: The invention of the present application provides a compound represented by Formula (I) or a salt thereof, which exhibits an inhibitory activity against at least one kinase selected from the group consisting of Akt kinase, Rsk kinase, and S6K kinase and/or a cell proliferation inhibiting effect and is useful as a prophylactic and/or therapeutic agent for diseases associated with the above-mentioned kinases, particularly cancer.
    Type: Grant
    Filed: May 19, 2017
    Date of Patent: January 21, 2020
    Assignee: Taiho Pahrmaceutical Co., Ltd.
    Inventors: Tetsuya Sugimoto, Toshihiro Sakamoto, Fuyuki Yamamoto, Yu Kobayakawa, Naoki Egashira, Koji Ichikawa, Takumitsu Machida